Understanding pain in depression

Human Psychopharmacology

Volumn 19, Issue SUPPL. 1, 2004, Pages

  Stahl, Stephen ^a   Briley, Mike ^b  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

^b NeuroBiz Consulting and Communication   (France)

Author keywords

Depression; Noradrenaline; Pain; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; MILNACIPRAN; MIRTAZAPINE; MONOAMINE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY; ATTENTION; BODY MOVEMENT; BRAIN REGION; CELLULAR DISTRIBUTION; CEREBELLUM; COGNITION; DEPRESSION; EMOTION; FEEDING BEHAVIOR; FIBROMYALGIA; HUMAN; INTESTINE; IRRITABLE COLON; LOCUS CERULEUS; MONOAMINE NERVE CELL; MOOD; MOTOR CONTROL; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; PAIN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RAPHE NUCLEUS; REVIEW; SENSORY STIMULATION; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SEXUAL BEHAVIOR; SKELETAL MUSCLE; SPINAL CORD; SYMPTOM;

DEPRESSION; HUMANS; NOREPINEPHRINE; PAIN; SEROTONIN;

EID: 6344282277     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.619     Document Type: Review

References (29)

1. Aaron LA, Buchwald D. 2001. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 134: 868-881.
2. Anderson IM, Tomenson BM. 1994. The efficacy of selective serotonin reuptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 8: 238-249.
3. Byrne SE, Rothschild AJ. 1998. Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatment. J Clin Psychiatry 59: 279-288.
4. Clerc G, Milnacipran/Fluvoxamine Study Group. 2001. Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine. Int Clin Psychopharmacol 16: 145-151.
5. Lopez-Ibor J, Guelfi JD, Pletan Y, et al. 1996. Milnacipran and selective serotonin reuptake inhibitors in major depression. Int Clin Psychopharmacol 11(Suppl. 4): 41-46.
6. Clerc GE, Ruimy P, Verdeau-Pailles J. 1994. A double blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol 9: 139-143.
7. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. 2000. Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med. 1 310-316.
8. Hudson JI, Mangweth B, Pope HG, et al. 2003. Family study of affective spectrum disorder. Arch Gen Psychiatry 60: 170-177.
9. Hudson JL, Pope HG. 1990. Affective spectrum disorder: does anti-depressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 147: 552-564.
10. Katon W, Sullivan M, Walker E. 2001. Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med 134: 917-925.
11. Keller MB, Lavori PW, Mueller TI, et al. 1992. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 49: 809-816.
12. Kirmayer LJ, Robbins JM, Dworkind M, et al. 1993. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 150: 734-741.
13. Kroenke K, Spitzer RL, Williams JB, et al. 1994. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med 3: 774-779.
14. Nelson JC, Mazure CM, Bowers MB, et al. 1991. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 48 303-307.
15. Ohayon MM, Schatzberg AF. 2003. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry 60: 39-47.
16. Perry PJ. 1996. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord 39 1-6.
17. Roose SP, Glassman AH, Attia E, et al. 1994. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 151 1735-1739.
18. Simon GE, VonKorff M, Piccinelli M, et al. 1999. An international study of the relation between somatic symptoms and depression. N Engl J Med 99: 1329-1335.
19. Stahl SM. 2000. Essential Psychopharmacology, 2nd edn. Cambridge University Press: New York, NY.
20. Stahl SM. 2003. Antidepressants and somatic symptoms: therapeutic actions are expanding beyond affective spectrum disorders to functional somatic syndromes. J Clin Psychiatry 64: 745-746.
21. Stahl SM. 2001a. Fibromyalgia: the enigma and the stigma. J Clin Psychiatry 62: 501-502.
22. Stahl SM. 2001b. Gut feelings about irritable bowel syndrome. J Clin Psychiatry 62: 590-591.
23. Stahl SM. 2002a. The psychopharmacology of energy and fatigue. J Clin Psychiatry 63: 7-8.
24. Stahl SM. 2002b. The psychopharmacology of painful physical symptoms in depression. J Clin Psychiatry 63: 282-283.
25. Staiger TO, Gaster B, Sullivan MD, Deyo RA. 2003. Systematic review of antidepressants in the treatment of chronic low back pain. Spine 28: 2540-2545.
26. Thase ME, Entsuah AR, Rudolph RL. 2001. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 178: 234-241.
27. Thase ME, Rush AJ. 1997. When at first you don't succeed: sequential strategies for antidepressant non-responders. J Clin Psychiatry 58(Suppl. 13): 23-29.
28. Wall PD, Melzack R. 1999. Textbook of Pain, 4th edn. Churchill Livingston: New York, NY.
29. Wu LR, Parkerson GR, Jr, Doraiswamy PM. 2002. Health perception, pain, and disability as correlates of anxiety and depression symptoms in primary care patients. J Am Board Fam Pract 15: 183-190.